GRASS VALLEY, Calif., Feb. 25, 2011 /PRNewswire/ — As a world
leader in the advancement of the detection and treatment of
prostate cancer, the Smilow Comprehensive Prostate Cancer Center
(www.smilowprostatecancercenter.com) at NYU
Langone Medical Center is the first medical facility in the
Northeast to install ei-Nav|Artemis™, an innovative image
guidance and navigation system for prostate biopsy that is
manufactured by Eigen.
Using proprietary next-generation imaging technology, Artemis
provides solutions not available today by enhancing urologists’
existing ultrasound machines, the vast majority of which are only
2D. Artemis lets urologists virtually see inside the prostate
in 3D while providing real-time needle navigation and biopsy needle
mapping. It also generates a 3D image of the biopsy
coordinates for future reference.
“We are very excited about Artemis,” says Herbert Lepor, MD,
Director of the Smilow Comprehensive Prostate Cancer Center.
“No major advances have been made in the TRUS/biopsy technique over
the past 20 years, except for use of local anesthesia and a 12-core
approach. This new device helps the Smilow Center provide the most
sophisticated level of prostate diagnosis possible and assists our
physicians in providing even better prostate cancer treatment and
management, especially for men electing active surveillance and
focal therapy.”
Artemis lets doctors select a tissue site within the boundary of
the prostate with near-pinpoint accuracy and then provides needle
navigation to the precise location for biopsy. Artemis’
patented registration technology records this data in 3D, which
allows doctors to revisit or avoid the exact same area during
repeat procedures. Artemis provides doctors with data they can
analyze to determine changes in the prostate gland and manage
treatment accordingly.
“With an estimated 1.5 million biopsies performed each year,
conventional
‘/>”/>
